Oncodesign Precision Medicine - OPM

📍 Dijon, France🗓 Founded 2022👥 17 employees
Biotechnology Research🌐 oncodesign.com
Website LinkedIn
OPM is a technological company specialized in precision medicine. OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments. For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors. To discuss partnership or investment, don't hesitate to get in touch : info@oncodesign.com
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Oncodesign Precision Medicine - OPM founded?
Oncodesign Precision Medicine - OPM was founded in 2022.
What industry is Oncodesign Precision Medicine - OPM in?
Oncodesign Precision Medicine - OPM operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oncodesign Precision Medicine - OPM based?
Oncodesign Precision Medicine - OPM is headquartered in Dijon, France.